Davide Lazzarotto
University of Udine
39 Papers
40 Citations
Davide Lazzarotto is an academic researcher from University of Udine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 17 publications. Previous affiliations of Davide Lazzarotto include Misericordia University.
Chat about Author
Papers
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
Cristina Cattaneo,R Di Blasi,Cristina Skert,Anna Candoni,Bruno Martino,N. Di Renzo,Mario Delia,Stelvio Ballanti,Francesco Marchesi,Valentina Mancini,Enrico Orciuolo,Simone Cesaro,Lucia Prezioso,Rosa Fanci,Gianpaolo Nadali,Anna Chierichini,Luca Facchini,Marco Picardi,Michele Malagola,Vincenza Orlando,Enrico Maria Trecarichi,Mario Tumbarello,Franco Aversa,Giorgio Rossi,Livio Pagano,Angela Passi,Doriana Gramegna,Domenico Russo,Davide Lazzarotto,Domenico Rotilio,Maria Rosaria De Paolis,Edoardo Simonetti,Maria Alessandra Innocente,Antonio Spadea,Francesco Mazziotta,Anna Pegoraro,Angelica Spolzino,Gloria Turri,Barbara Veggia +38 more
TL;DR: MDR rectal colonization occurs in 6.5% of haematological inpatients and predicts a 16% probability of MDRrel BSI, particularly during neutropenia, as well as a higher probability of unfavourable outcomes in CR-rel BSIs.
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study
Anna Candoni,Davide Lazzarotto,Felicetto Ferrara,Antonio Curti,Federico Lussana,Cristina Papayannidis,Maria Ilaria Del Principe,Massimiliano Bonifacio,Federico Mosna,Mario Delia,Paola Minetto,Michele Gottardi,Nicola Stefano Fracchiolla,Valentina Mancini,Fabio Forghieri,Patrizia Zappasodi,Marco Cerrano,Antonella Vitale,Ernesta Audisio,Silvia Trappolini,Claudio Romani,Marzia Defina,Silvia Imbergamo,Nadia Ciccone,Lidia Santoro,Benedetta Cambò,Salvatore Iaccarino,Michela Dargenio,Lara Aprile,Sabina Chiaretti,Renato Fanin,Giovanni Pizzolo,Roberto Foa +32 more
TL;DR: Taking into account the poor prognosis of this patient population, nelarabine represents an effective option with an ORR of 50% and a CR rate of 36% and in addition, 40% of cases following nelARabine salvage therapy could undergo SCT with an expected OS at 2 and 5 years of 46% and 38%, respectively.
58
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)
Anna Candoni,Alessandro Rambaldi,Renato Fanin,Andrea Velardi,William Arcese,Fabio Ciceri,Davide Lazzarotto,Federico Lussana,Jacopo Olivieri,Giovanni Grillo,Matteo Parma,Benedetto Bruno,Federica Sorà,Paolo Bernasconi,Riccardo Saccardi,Robin Foà,Mariarosa Sessa,Paola Bresciani,Fabio Giglio,Alessandra Picardi,Alessandro Busca,Simona Sica,Katia Perruccio,Elisa Zucchetti,Elisa Diral,Anna Paola Iori,Anna Amelia Colombo,Stefano Tringali,Stella Santarone,Giuseppe Irrera,Stefano Mancini,Francesco Zallio,Michele Malagola,Francesco Albano,Angelo Michele Carella,Attilio Olivieri,Cristina Tecchio,Alida Dominietto,Adriana Vacca,Roberto Sorasio,Enrico Orciuolo,Antonio M. Risitano,Salvatore Leotta,Agostino Cortelezzi,Sonia Mammoliti,Elena Oldani,Francesca Bonifazi +46 more
TL;DR: It is confirmed that HSCT is a potentially curative treatment for Ph+ ALL with an excellent outcome for the subgroup of patients MRD-negative both at HSCT and at 3 months after HSCT (5 year OS 70%), and Evaluation of the mEBMT risk score can be useful to predict NRM.
46
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation
Francesca Patriarca,Chiara Cigana,Dozzo Massimo,Davide Lazzarotto,Antonella Geromin,Miriam Isola,Marta Lisa Battista,Marta Medeot,Michela Cerno,Alessandra Sperotto,Anna Candoni,Massimo Crapis,Assunta Sartor,Claudio Scarparo,Matteo Bassetti,Renato Fanin +15 more
TL;DR: It is concluded that eligibility to allogeneic HSCT in MDR GN bacteria carriers should be carefully evaluated together with all other factors that independently influence outcome (disease status, donor, and GVHD risk).
37
Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey
Davide Lazzarotto,Anna Candoni,Carla Filì,Fabio Forghieri,Livio Pagano,Alessandro Busca,Giuseppina Spinosa,Maria Elena Zannier,Erica Simeone,Miriam Isola,Erika Borlenghi,Lorella Melillo,Federico Mosna,Federica Lessi,Renato Fanin +14 more
TL;DR: Patients with MS, both with de novo and secondary forms, still have a very unfavorable outcome and require an intensive therapeutic program, that includes Allo-SCT whenever possible, and the outcome after Allo -SCT is positively influenced by the development of chronic GvHD suggesting a Graft versus MS effect.
34